Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS

ClinicalTrials.gov ID: NCT00206648

Public ClinicalTrials.gov record NCT00206648. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Rater-blinded, Multicenter, Parallel-group Study Comparing the Efficacy and Safety of Betaseron 250 µg Subcutaneously Every Other Day With Avonex 30 µg Intramuscularly Once Per Week in Relapsing-remitting Multiple Sclerosis Patients Previously Treated With Avonex

Study identification

NCT ID
NCT00206648
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bayer
Industry
Enrollment
271 participants

Conditions and interventions

Interventions

  • Betaferon/Betaseron Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2003
Primary completion
Not listed
Completion
Sep 30, 2005
Last update posted
Dec 30, 2014

2003 – 2005

United States locations

U.S. sites
51
U.S. states
27
U.S. cities
49
Facility City State ZIP Site status
Not listed Tucson Arizona 85741
Not listed Berkeley California 94705
Not listed Irvine California 92697
Not listed Loma Linda California 92354
Not listed Los Angeles California 90095-1721
Not listed Sacramento California 95817
Not listed San Jose California 95124
Not listed Walnut Creek California 94596
Not listed Walnut Creek California 94598
Not listed Wilmington Delaware 19806
Not listed Melbourne Florida 32940
Not listed Miami Florida 33136
Not listed Tampa Florida 33606
Not listed Tampa Florida 33609
Not listed Atlanta Georgia 30309-1465
Not listed Augusta Georgia 30912
Not listed Columbus Georgia 31909
Not listed Savannah Georgia 31405
Not listed Flossmoor Illinois 60422
Not listed Springfield Illinois 62703
Not listed Fort Wayne Indiana 46805
Not listed Indianapolis Indiana 46202
Not listed Des Moines Iowa 50314
Not listed Kansas City Kansas 66160
Not listed Shreveport Louisiana 71130
Not listed Baltimore Maryland 21201
Not listed Detroit Michigan 48201
Not listed Golden Valley Minnesota 55422
Not listed Minneapolis Minnesota 55455
Not listed Rochester Minnesota 55905
Not listed Kansas City Missouri 64108
Not listed St Louis Missouri 63110
Not listed Reno Nevada 89509
Not listed Albuquerque New Mexico 87131-5281
Not listed Albany New York 12208
Not listed Buffalo New York 14215
Not listed Mineola New York 11501
Not listed New York New York 10003
Not listed Asheville North Carolina 28801
Not listed Winston-Salem North Carolina 27157
Not listed Dayton Ohio 45409
Not listed Oklahoma City Oklahoma 73120
Not listed Medford Oregon 97504
Not listed Philadelphia Pennsylvania 19104
Not listed Providence Rhode Island 02905
Not listed Charleston South Carolina 29425
Not listed Houston Texas 77030
Not listed Fairfax Virginia 22031
Not listed Roanoke Virginia 24014
Not listed Seattle Washington 98101
Not listed Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00206648, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 30, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00206648 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →